Jeong Seon Ryu
Overview
Explore the profile of Jeong Seon Ryu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Lee Y, Park J, Cheon S, Ryu J, Shin J, et al.
J Korean Med Sci
. 2025 Feb;
40(5):e11.
PMID: 39938870
Background: Single room isolation with contact precautions is widely regarded as a fundamental strategy to prevent the transmission of multidrug-resistant organisms (MDROs). However, its implementation demands substantial resources, limiting its...
2.
Yeo C, Park D, Yoon S, Kim E, Lee J, Lee S, et al.
Clin Respir J
. 2025 Jan;
19(1):e70043.
PMID: 39757012
Introduction: The provision of treatment for epidermal growth factor receptor (EGFR)-mutated nonsmall cell lung cancer (NSCLC) patients has increased in Korea. However, multicenter studies on the clinicopathologic dataset and treatment...
3.
Choi J, Choi C, Chang Y, Lee K, Kim S, Yang S, et al.
Transl Lung Cancer Res
. 2023 Dec;
12(11):2275-2282.
PMID: 38090523
Background: Data from clinical trials and real-world studies show that afatinib is effective in treating non-small cell lung cancer (NSCLC) harboring activating mutations in the epidermal growth factor receptor ()...
4.
Kim J, Jang T, Choi C, Kim M, Yong Lee S, Park C, et al.
Transl Lung Cancer Res
. 2023 Jul;
12(6):1197-1209.
PMID: 37425421
Background: Overall survival (OS) in patients with non-small cell lung cancer (NSCLC) and brain metastases (BMs) is poor. We aimed to identify prognostic factors and ascertain treatment outcomes of first-line...
5.
Kim T, Jang T, Choi C, Kim M, Yong Lee S, Chang Y, et al.
Cancer Res Treat
. 2023 May;
55(4):1152-1170.
PMID: 37218139
Purpose: This study aimed to report the final analysis of time-on-treatment (TOT) and overall survival (OS) in patients with advanced-stage epidermal growth factor receptor (EGFR)+ non-small cell lung cancer (NSCLC)...
6.
Kim M, Choi C, Yong Lee S, Park C, Chang Y, Lee K, et al.
Anticancer Res
. 2022 Feb;
42(3):1615-1622.
PMID: 35220259
Background/aim: Non-small cell lung cancers (NSCLCs) harboring uncommon epidermal growth factor receptor (EGFR) mutations are heterogeneous and show variable prevalence and clinical responses to EGFR tyrosine kinase inhibitors. We investigated...
7.
Yong Lee S, Choi C, Chang Y, Lee K, Kim S, Yang S, et al.
Transl Lung Cancer Res
. 2022 Jan;
10(12):4353-4367.
PMID: 35070746
Background: We investigated the clinical characteristics and treatment outcomes of Korean patients receiving first-line afatinib for advanced epidermal growth factor receptor mutation-positive (m) non-small cell lung cancer (NSCLC) in a...
8.
Kim T, Jang T, Choi C, Kim M, Yong Lee S, Park C, et al.
Cancer Med
. 2021 Jul;
10(17):5809-5822.
PMID: 34258882
Objectives: The optimal sequence for the administration of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for treating non-small cell lung cancer (NSCLC) is still unclear. This study aimed...
9.
Kim S, Wi Y, Yun S, Ryu J, Shin J, Lee E, et al.
J Korean Med Sci
. 2021 Apr;
36(14):e107.
PMID: 33847085
Coronavirus disease 2019 vaccinations for healthcare workers (HCWs) have begun in South Korea. To investigate adverse events (AEs) of the first dose of each vaccine, any symptom was collected daily...
10.
Lee H, Kim L, Kim C, Kim J, Nam H, Ryu J
Respir Med Case Rep
. 2020 Jun;
30:101086.
PMID: 32489848
Ground glass opacities, consolidation, and pleural effusions are observed in herpes simplex virus (HSV) pneumonia. Neither necrosis nor cavitation has been reported in areas of parenchymal disease. We describe a...